Clinical Trials

B.J. Rimel, MD, has been named medical director of the Cedars-Sinai Cancer Clinical Trials Office.

In a company release, Roche announced a collaboration on a new phase 3 Alzheimer’s disease prevention trial, which will test an investigational subcutaneous anti-amyloid antibody.

Children, adolescents and older adults were underrepresented in U.S. clinical trials investigating eating disorders, despite federal guidance urging increased participation of individuals of all ages, according to researchers.

The American Kidney Fund announced a new campaign focused on encouraging “communities of color” to participate in kidney disease clinical trials.

In this episode, Aaron Gerds, MD, discusses his work on clinical trials and suggestions to improve the process, the impact of COVID on these trials and his involvement in ASH Clinical News.

Swiss-based biopharmaceutical company AC Immune SA announced promising new interim data on the safety and efficacy of its ACI-35.030 vaccine for patients with early Alzheimer’s disease, according to a company press release.

Cancer clinical trials supporting FDA approvals significantly differ in reporting of withdrawal of consent or loss to follow-up and early drug discontinuation for adverse events, according to study results.

Despite the COVID-19 pandemic sparking more diverse research practices, individuals with disabilities have largely been excluded from such progress, according to a perspective published in The New England Journal of Medicine.

Studies using observational data to compare drug effectiveness must report the proportion of patients who stop or alter therapies and the reasons for treatment discontinuation, according to new EULAR “points to consider.”

Psychedelic therapy appeared associated with large acute and sustained reductions in suicidality, according to results of a meta-analysis published in the Journal of Clinical Psychiatry.